Arrowhead Pharmaceuticals Inc (ARWR) institutional holders · rev $829.4M
Arrowhead Pharmaceuticals Inc 13F cache, top 6 holders by reported value.
| Holder | Shares | Value | Report |
|---|---|---|---|
| VANGUARD GROUP INC | 14,159,706 | $940.06B | 2025-12-31 |
| STATE STREET CORP | 5,694,640 | $464.17B | 2026-06-30 |
| FMR LLC | 4,810,131 | $392.07B | 2026-06-30 |
| BlackRock Finance, Inc. | 9,997,536 | $259.84B | 2024-06-30 |
| GOLDMAN SACHS GROUP INC | 1,214,899 | $76.17B | 2026-03-31 |
| CITADEL ADVISORS LLC | 187,000 | $11.72B | 2026-03-31 |
FAQ
What is ARWR P/E and revenue?
Arrowhead Pharmaceuticals Inc (ARWR) rev $829.4M.
Who owns ARWR?
Arrowhead Pharmaceuticals Inc cache lists 6 13F holders by reported market value.
Not investment advice. Cached rows, not a live tape.